Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Takeda

Takeda

May 26, 2020

Takeda's Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer

The approval was based on data showing superior efficacy for Alunbrig compared to Pfizer's Xalkori, especially in patients with brain metastasis.

Apr 27, 2020

Rockefeller University, Cerevance Pursue Pooled Nuclei Sequencing to Target Brain Cell Types

Premium

Cerevance, a drug discovery firm employing the transcriptome sequencing method, raised $45 million in Series B financing earlier this month.

Aug 15, 2019

HiFiBio Bets on Single-Cell Methods to Boost Drug Discovery

Premium

The international firm is one of several pharmaceutical companies emphasizing new single-cell technologies to improve existing drugs and find new ones.

Oct 09, 2018

ERS Genomics Licenses CRISPR-Cas9 Genome Editing IP to GenAhead Bio

GenAhead said it will use the IP it had licensed from ERS for genome editing applications in pharmaceutical drug discovery and development.

May 01, 2018

Thermo Fisher Inks New Pharma Partnerships to Expand CDx Use of Oncomine NGS Test

The company announced agreements to use the Oncomine Dx Target Test in drug development programs with Daiichi Sankyo, Takeda, and Spectrum Pharmaceuticals.

Nov 07, 2016

Takeda Adopts Definiens Biomarker Analysis Platform

Takeda will use Definiens' new cloud-based digital pathology platform to conduct analyses for its clinical biomarkers development programs.

Sep 12, 2016

HudsonAlpha to Provide Sequencing Services for ORIEN Cancer Initiative

HudsonAlpha researchers are expected to sequence 20,000 patient tumor and non-tumor samples for ORIEN's Avatar initiative by 2019.

Jun 30, 2016

Exosome Diagnostics Inks RNA-Seq Collaboration With Takeda

The partners will develop a biomarker discovery platform based on Exosome Diagnostics' exosomal RNA sequencing technology.

Jun 16, 2016

Takeda, M2Gen Launch Genomic Data Program to Match Patients to Cancer Trials

The Avatar Research Program will collect de-identified genomic and clinical information from consenting patients treated at ORIEN cancer centers.

May 28, 2015

Takeda Partners with Sanford-Burnham on Heart Failure Research

The partners will screen for molecules that could revive metabolic activity in heart tissue damaged by cardiovascular disease or failure.

Pages

The Scan

Working Out the Effect

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Increased Genetic Privacy in Florida

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

Attention-Grabbing in Two Ways

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

Nature Papers Describe CRISPR Plant Editing Methods, DNA-PAINT Improvements, More

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.